Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris

Next Previous
X
Search
Trial Profile

LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 05 Jul 2022

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Betamethasone-dipropionate/calcipotriol (Primary)
  • Indications Plaque psoriasis
  • Focus Registrational; Therapeutic Use
  • Acronyms PSO-LONG
  • Sponsors LEO Pharma

    • Most Recent Events

    • 01 Jul 2022 Results of this post-hoc analysis published in the Journal of the European Academy of Dermatology and Venereology
    • 01 Jun 2022 Results of this post-hoc analysis assessing published long-term PAM with Cal/BD foam in PSO-LONG patients who could be more susceptible to corticosteroid-induced hypothalamic-pituitary-adrenal (HPA) axis suppression in the Journal of Dermatological Treatment
    • 01 Jun 2022 Results of a post-hoc analysis assessing clinical and patient-reported benefits of proactive versus reactive management with Betamethasone-dipropionate-calcipotriol foam published in the Journal of Dermatological Treatment

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top